🔎 Trials Near Me

ホーム › 骨髄増殖性腫瘍 › カリフォルニア州

カリフォルニア州における骨髄増殖性腫瘍の臨床試験

カリフォルニア州内の拠点で、骨髄増殖性腫瘍に関する17件の研究が参加者を募集しています。

カリフォルニア州内の都市

公式研究テキスト(英語)

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

  • Kaiser Permanente Dublin, Dublin
  • Kaiser Permanente-Fremont, Fremont
  • Kaiser Permanente Fresno Orchard Plaza, Fresno
  • 他21件
被験者募集中第2相
18歳以上 · 全性別 · 2026/10/05更新 · NCT05564390

A Phase 1 Study of PRT12396 in Participants With Select Myeloproliferative Neoplasms

  • UCLA Ronald Reagan Medical Center, Los Angeles
被験者募集中第1相
18歳以上 · 全性別 · 2026/10/01更新 · NCT07469891

A Randomized Study of ASTX727 With or Without Iadademstat in Advanced Myeloproliferative Neoplasms (MPNs)

  • UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine
  • UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange
  • Stanford Cancer Institute Palo Alto, Palo Alto
  • 他1件
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/30更新 · NCT06661915

Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia

  • City of Hope - Duarte, Duarte
  • City of Hope - Lennar, Irvine
  • UCLA, Los Angeles
  • 他1件
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/23更新 · NCT05320198

Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)

  • Cedars-Sinai Medical Center, Los Angeles
  • Kaiser Permanente-Oakland, Oakland
  • Kaiser Permanente-Roseville, Roseville
  • 他3件
被験者募集中第2相
18歳〜59歳 · 全性別 · 2026/09/22更新 · NCT05554406

(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis

  • City of Hope Comprehensive Cancer Center, Duarte
  • UCLA Medical Center, Los Angeles
  • Stanford Cancer Institute, Stanford
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/15更新 · NCT04996875

Project: Every Child for Younger Patients With Cancer

  • Kaiser Permanente Downey Medical Center, Downey
  • City of Hope Comprehensive Cancer Center, Duarte
  • Loma Linda University Medical Center, Loma Linda
  • 他15件
被験者募集中観察研究
25歳以下 · 全性別 · 2026/08/25更新 · NCT02402244

A Study to Evaluate INCA035784 in Participants With Myeloproliferative Neoplasms

  • Stanford University, Palo Alto
被験者募集中第1相
18歳以上 · 全性別 · 2026/08/06更新 · NCT07008118

A Vaccine (CMV-MVA Triplex Vaccine) for the Enhancement of CMV-Specific Immunity and the Prevention of CMV Viremia in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplant

  • City of Hope Medical Center, Duarte
被験者募集中第1相健康なボランティア歓迎
18歳〜75歳 · 全性別 · 2026/07/28更新 · NCT07020533

Study of INCA036978 in Participants With Myeloproliferative Neoplasms

  • City of Hope-Lennar Foundation Cancer Center, Irvine
  • Usc Norris Comprehensive Cancer Center, Los Angeles
  • UCLA Medical Hematology & Oncology, Los Angeles
被験者募集中第1相
18歳以上 · 全性別 · 2026/07/22更新 · NCT07441694

A Study to Evaluate INCA033989 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasms

  • City of Hope Medical Center, Duarte
  • Stanford Cancer Institute, Palo Alto
被験者募集中第1相
18歳以上 · 全性別 · 2026/04/17更新 · NCT06034002

An Optimal Dose Finding Study of N-Acetylcysteine in Patients With Myeloproliferative Neoplasms

  • University of California, Irvine, Irvine
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/03/10更新 · NCT05123365

CMV-MVA Triplex Vaccination in HLA-Matched Related Stem Cell Donors for the Prevention of CMV Infection in Patients Undergoing Hematopoietic Stem Cell Transplant

  • City of Hope Medical Center, Duarte
被験者募集中第2相健康なボランティア歓迎
18歳〜75歳 · 全性別 · 2026/03/10更新 · NCT06059391

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

  • Massive Bio SYNERGY-AI site, Duarte
  • Massive Bio SYNERGY-AI site, Irvine
  • Massive Bio SYNERGY-AI site, La Jolla
  • 他3件
被験者募集中観察研究
全年齢 · 全性別 · 2025/10/28更新 · NCT03452774

Leading in MPNs Beyond Ruxolitinib in Combo With T-Regs

  • UC Davis Health, Sacramento
被験者募集中第1相
18歳以上 · 全性別 · 2025/04/13更新 · NCT05423691

ClinicalTrials.govより、2026/10/06時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。